Leading science, pioneering therapies

CRM Publications

Type a few characters, select from list

2016

Castillo S.D, Tzouanacou E., Zaw-Thin M., Berenjeno I.M, Parker V.ER, Chivite I., Mila-Guasch M., Pearce W., Solomon I., Angulo-Urarte A. et al..  2016.  Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humansScience Translational Medicine. 8(332):332ra43-332ra43.
Easterbrook J, Fidanza A, Forrester LM.  2016.  Concise review: programming human pluripotent stem cells into bloodBritish Journal of Haematology. :n/a-n/a.
Wymeersch FJ, Huang Y, Blin G, Cambray N, Wilkie R, Wong FCk, Wilson V.  2016.  Position-dependent plasticity of distinct progenitor types in the primitive streak.Elife. 5
Mascarenhas MI, Bacon WA, Kapeni C, Fitch SR, Kimber G, Cheng SWPriscill, Li J, Green AR, Ottersbach K.  2016.  Analysis of Jak2 signaling reveals resistance of mouse embryonic hematopoietic stem cells to myeloproliferative disease mutation.Blood. 127((19)):2298-309.
Garros-Regulez L, Aldaz P, Arrizabalaga O, Moncho-Amor V, Carrasco-Garcia E, Manterola L, Moreno-Cugnon L, Barrena C, Villanua J, Ruiz I et al..  2016.  mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance.Expert Opin Ther Targets. 20(4):393-405.
Mollereau B, Rzechorzek NM, Roussel BD, Sedru M, Van den Brink D, Bailly-Maitre B, Palladino F, Medinas DB, Domingos PM, Hunot S et al..  2016.  Adaptive preconditioning in neurological diseases - Therapeutic insights from proteostatic perturbations.Brain Res.
Rzechorzek NM, Connick P, Livesey MR, Borooah S, Patani R, Burr K, Story D, Wyllie DJA, Hardingham GE, Chandran S.  2016.  Hypothermic Preconditioning Reverses Tau Ontogenesis in Human Cortical Neurons and is Mimicked by Protein Phosphatase 2A Inhibition.EBioMedicine. 3:141-54.
Long K, Moss L, Laursen L, Boulter L, ffrench-Constant C.  2016.  Integrin signalling regulates the expansion of neuroepithelial progenitors and neurogenesis via Wnt7a and Decorin.Nat Commun. 7:10354.
Pollard SM, M Marqués-Torrejón Á.  2016.  Give it a REST!Elife. 5
Livesey MR, Magnani D, Cleary EM, Vasistha NA, James OT, Selvaraj BT, Burr K, Story D, Shaw CE, Kind PC et al..  2016.  Maturation and electrophysiological properties of human pluripotent stem cell-derived oligodendrocytes.Stem Cells.
Mirantes C, Dosil MAlba, Hills D, Yang J, Eritja N, Santacana M, Gatius S, Vilardell F, Medvinsky A, Matias-Guiu X et al..  2016.  Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma, but not myeloid malignancies.Blood.
Engert A, Balduini C, Brand A, Coiffier B, Cordonnier C, Döhner H, de Wit TDuyvene', Eichinger S, Fibbe W, Green T et al..  2016.  The European Hematology Association Roadmap for European Hematology Research. A Consensus Document.Haematologica.
Gow AG, Muirhead R, Hay DC, Argyle DJ.  2016.  Low-Density Lipoprotein Uptake Demonstrates a Hepatocyte Phenotype in the Dog, but Is NonspecificStem Cells and Development. 25(1):90-100.
Shen J, Shrestha S, Yen Y-H, Scott MA, Soo C, Ting K, Péault B, Dry SM, James AW.  2016.  The pericyte antigen RGS5 in perivascular soft tissue tumorsHuman Pathology. 47(1):121-131.

2015

van Erp S, van den Heuvel DMA, Fujita Y, Robinson RA, Hellemons AJCGM, Adolfs Y, Van Battum EY, Blokhuis AM, Kuijpers M, Demmers JAA et al..  2015.  Lrig2 Negatively Regulates Ectodomain Shedding of Axon Guidance Receptors by ADAM Proteases.Dev Cell. 35(5):537-52.
Canham MA, Van Deusen A, Brison DR, De Sousa PA, Downie J, Devito L, Hewitt ZA, Ilic D, Kimber SJ, Moore HD et al..  2015.  The Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines.Sci Rep. 5:17258.
Holmqvist S, Brouwer M, Djelloul M, Diaz AGarcia, Devine MJ, Hammarberg A, Fog K, Kunath T, Roybon L.  2015.  Generation of human pluripotent stem cell reporter lines for the isolation of and reporting on astrocytes generated from ventral midbrain and ventral spinal cord neural progenitors.Stem Cell Res. 15(1):203-20.
Vesterinen HM, Connick P, Irvine CMJ, Sena ES, Egan KJ, Carmichael GG, Tariq A, Pavitt S, Chataway J, Macleod MR et al..  2015.  Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis.PLoS One. 10(4):e0117705.

Pages